Pharma IQ Members

Business Development

Are you a service provider to the pharma/bio industry? Find out the invaluable steps you can take to develop your business. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in business development and marketing to exchange ideas on best practice and share case studies on business development, strategy, advertising and marketing for the pharmaceutical, biotechnology and healthcare sectors.

Contributor: Social Monsters.org
Posted: 14/02/2017
default profile icon
After years of resistance, the health care and pharmaceutical industries are now accelerating full steam towards the cloud. In fact, the global health care cloud computing market, valued at $4.5 billion in 2016, will reach $9.5 billion by 2020. Here are the dominant benefits that are drawing these giants to the cloud. Full Article »
Contributor: Chanice Henry
Posted: 05/04/2016
Miss Chanice Henry
Pharma IQ zooms through the latest predicted trends for the compound and biological sample management industries. The video explores investment levels, team sizes, top challenges and areas for growth. Full Video »
Contributor: Andrea Charles
Posted: 18/06/2012
If you can't talk, are you listening? A big challenge for many social media marketers and business development personnel is control. In this Pharma IQ podcast we address common issues companies are facing engaging in heavily regulated industries like Pharma. Shirley Williams, Principal Consultant, Owner at Social Media Pearls delivers her top Full Podcast »
Contributor: George Clinical Representative
Posted: 02/08/2016
Georger
Extensive investigator networks, cultivated over the course of some of the world’s largest clinical trials into the risk factors for dementia, present an exciting opportunity for the future of dementia trials. Diabetes, hypertension, stroke, vascular disease, smoking, poor diet, physical inactivity and even depression have been linked to an increase in the likelihood of an individual presenting with dementia at some point in their lives Full Column »
Contributor: Pharma IQ
Posted: 14/02/2017
Pharma IQ
We spoke to CRISPR experts Robin Ketteler and Lorena Benedetti to find out about their work within CRISPR, insights on where the technique is heading and the field’s exciting developments. Full Whitepaper »